Forest Laboratories Inc. joined the litany of big pharma companies announcing restructuring programs last week. But the major restructuring, dubbed Project Rejuvenate, appears to be more about streamlining operations than downsizing. Read More
A recent report on the cost of bringing an asset from discovery to the market place has increased significantly for pharmaceutical companies over the last four years but returns on their investments have not kept pace. This state-of-affairs has caused these firms to adjust their business plans accordingly. Read More
